INFLUENCE OF SLEEP DISRUPTION AND CALORIE RESTRICTION ON BIOLOGICAL MARKERS FOR DEPRESSION

The hypothesis that the dexamethasone suppression test (DST) and rapid-eye-movement (REM) latency test are not biological markers for depressive illness but artifacts arising from dietary and sleep disturbances that accompany depression was examined in 28 normal volunteers. The restriction of calorie intake with moderate weight loss reproduced a pattern of response to dexamethasone closely resembling that claimed to be diagnostic of depressive illness. The shortened REM latencies claimed as a diagnostic marker were replicated in volunteers by mimicking the sleep pattern commonly found in depression. These changes could not be explained by the induction of mood disorder in the subjects. The results put in question the diagnostic value of the DST and REM latency tests in clinical practice, where sleep disorder and poor appetite, with reduced calorie intake, are the common accompaniments of depressive illness.

[1]  A. Rechtschaffen,et al.  A manual of standardized terminology, technique and scoring system for sleep stages of human subjects , 1968 .

[2]  B. Carroll.  DEXAMETHASONE SUPPRESSION TEST IN DEPRESSION , 1980, The Lancet.

[3]  D. Kupfer,et al.  Distribution of REM latency in depression. , 1981, Biological psychiatry.

[4]  J. Endicott,et al.  Plasma cortisol secretion and REM period latency in adult endogenous depression. , 1983, The American journal of psychiatry.

[5]  K. Pirke,et al.  Influence of weight loss on the dexamethasone suppression test. , 1983, Archives of general psychiatry.

[6]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[7]  D. J. Mullaney,et al.  Sleep during and after gradual sleep reduction. , 1977, Psychophysiology.

[8]  M. Kline,et al.  Weight loss and the dexamethasone suppression test. , 1983, Archives of general psychiatry.

[9]  B. Carroll,et al.  A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. , 1981, Archives of general psychiatry.

[10]  P. Roy-Byrne,et al.  Effects of weight loss on the dexamethasone suppression test. , 1983, The American journal of psychiatry.

[11]  B. Carroll,et al.  The Carroll Rating Scale for Depression , 1986 .

[12]  G. Keitner,et al.  Results of the dexamethasone suppression test in psychiatric patients with and without weight loss. , 1985, The American journal of psychiatry.

[13]  K. Wood,et al.  Depression, Weight Loss and the Dexamethasone Suppression Test , 1984, British Journal of Psychiatry.

[14]  B. Carroll,et al.  Biological 'markers' for endogenous depression. Effect of age, severity of illness, weight loss, and polarity. , 1984, Archives of general psychiatry.

[15]  S. Targum.  Reported weight loss and the dexamethasone suppression test , 1983, Psychiatry Research.

[16]  V. Nowlis.  Research with the mood adjective checklist , 1965 .

[17]  W. Coryell,et al.  Appetite and weight change and the dexamethasone suppression test. , 1984, Biological psychiatry.

[18]  D. Kupfer.  Neurophysiological "markers"--EEG sleep measures. , 1984, Journal of psychiatric research.

[19]  Bernard J. Carroll,et al.  Dexamethasone Suppression Test , 1984 .

[20]  B. Carroll.  The Dexamethasone Suppression Test for Melancholia , 1982, British Journal of Psychiatry.

[21]  B. Carroll,et al.  Biological markers for endogenous depression in series and parallel. , 1984, Biological psychiatry.

[22]  L. Braddock.  The Dexamethasone Suppression Test , 1986, British Journal of Psychiatry.

[23]  D. Kupfer,et al.  Sleep continuity changes in depression. , 1973, Diseases of the nervous system.

[24]  K. Pirke,et al.  Hypothalamic Pituitary Function in Starving Healthy Subjects , 1984 .

[25]  B. Carroll,et al.  The Carroll Rating Scale for Depression I. Development, Reliability and Validation , 1981, British Journal of Psychiatry.